Wuwei Yang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Sarcoma Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Medical Imaging and Pathology Studies 2
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Donggang Xu (1 shared paper)Li Li (1 shared paper)Kaiwen Hu (3 shared papers)Peng Huang (2 shared papers)Jing Lin (2 shared papers)Dong Zheng (2 shared papers)Yongping Yang (2 shared papers)Linjing An (2 shared papers)
- Journals
- Liver International (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Cancer Immunology Immunotherapy (1 paper)The Oncologist (1 paper)Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wuwei Yang
21 papers receiving 607 citations
Peers
Comparison fields: 5 of 92
- Hepatology 206
- Biomaterials 87
- Oncology 124
- Pulmonary and Respiratory Medicine 136
- Pharmaceutical Science 21
Countries citing papers authored by Wuwei Yang
This map shows the geographic impact of Wuwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuwei Yang more than expected).
Fields of papers citing papers by Wuwei Yang
This network shows the impact of papers produced by Wuwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuwei Yang. The network helps show where Wuwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 185 | |
| 2 | 2018 | 103 | |
| 3 | 2014 | 67 | |
| 4 | 2017 | 43 | |
| 5 | 2017 | 42 | |
| 6 | Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. | 2005 | 26 |
| 7 | 2018 | 24 | |
| 8 | 2014 | 20 | |
| 9 | 2019 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2018 | 10 | |
| 14 | [Study on the efficacy and safety of ultrasound ablation in treatment of uterine fibroids]. | 2010 | 9 |
| 15 | 2012 | 8 | |
| 16 | 2022 | 7 | |
| 17 | [Analysis of complications of high intensity focused ultrasound in treatment of uterine leiomyoma]. | 2010 | 5 |
| 18 | 2017 | 4 | |
| 19 | 2018 | 2 | |
| 20 | Clinical significance of using B-mode ultrasonography to determine the quantity of pleural fluid | 2004 | 1 |
About Wuwei Yang
Wuwei Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Biomedical Engineering and Epidemiology, having authored 21 papers that have together received 614 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), Nanoplatforms for cancer theranostics (2 papers), Medical Imaging and Pathology Studies (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Hepatology (206 citations), Biomaterials (87 citations), Oncology (124 citations), Pulmonary and Respiratory Medicine (136 citations) and Pharmaceutical Science (21 citations). Wuwei Yang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Donggang Xu, Li Li, Kaiwen Hu, Peng Huang, Jing Lin, Dong Zheng, Yongping Yang, Linjing An, Xiujuan Chang and Hui Xie. Their work appears in journals such as Liver International, JNCI Journal of the National Cancer Institute, Cancer Immunology Immunotherapy, The Oncologist and Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.